Regarding artificial blood vessels used for the treatment of aortic aneurysms, medical device manufacturers in Tokyo have begun voluntary recovery because they may cause rupture of the aortic aneurysms in the worst case, such as damage in the body.
Voluntarily collected are artificial blood vessels imported from Ireland by "Nippon Medtronic" in Minato-ku, Tokyo and sold under the name of "Chest Stent Graft System".
It is used for patients such as aortic aneurysm, but according to the company, cases of patient death after being damaged in a blood vessel last December have been reported overseas.
In addition to this, one case of damage and seven cases of defective parts were reported overseas, and the company began voluntary collection on the 18th, saying that it may cause rupture of the aneurysm.
The target is about 5,200 products shipped to 312 medical institutions in Japan from October to 9th of this month, and at least more than 2,200 have already been used by patients.
Since no health hazards have been reported so far, Medtronic Japan said, "We apologize for the inconvenience. We will proceed with the collection as soon as possible and provide information to medical institutions so that we can take appropriate measures. I want to. "